Publications
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Autoimmune diseases of the central nervous system in cases2017 | First Faculty of Medicine
- Advancements in symptomatic treatment of multiple sclerosis2012 | First Faculty of Medicine
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis2011 | Publication without faculty affiliation
- Does the Development of Urinary Dysfunction in Multiple Sclerosis Depend on the Type of Neurological Treatment?2007 | First Faculty of Medicine
- Osteoporosis in multiple sclerosis patients: dependence on corticosteroid therapy and motor deficit2004 | First Faculty of Medicine
- Mitoxanthrone in the treatment of active Multiple sclerosis (MS)2003 | First Faculty of Medicine
- Micturitional complaints in patients with multiple sclerosis2001 | First Faculty of Medicine
- Rate of bone loss in multiple sclerosis patients treated with glucocorticoids is best explained by physical performancePublication without faculty affiliation
- Bone loss in multiple sclerosis patients treated with corticosteroidsPublication without faculty affiliation
Loading network view...
